JULIE THIBEAUX: Open Payments
NPI 1871368985 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,260 in 57 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $989 · 2025 $1,260
Food & beverage: $1,260
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $203 |
| Supernus Pharmaceuticals, Inc. | 5 | $181 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $171 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $144 |
| Corium, LLC | 5 | $132 |
| Axsome Therapeutics, Inc. | 4 | $99 |
| Collegium Pharmaceutical, Inc. | 4 | $85 |
| E.R. Squibb & Sons, L.L.C. | 3 | $53 |
| Tris Pharma Inc | 2 | $44 |
| Noven Therapeutics, LLC | 2 | $33 |
Products named: VRAYLAR, Qelbree, CAPLYTA, TRINTELLIX, Azstarys, Auvelity, Jornay PM, COBENFY.
Industry payments across TX — which companies pay providers there.
